Krsnaa Diagnostics Limited (IN:KRSNAA)
:KRSNAA
KRSNAA Stock Chart & Stats
₹735.10
₹3.75(0.41%)
At close: 4:00 PM EST
₹735.10
₹3.75(0.41%)
Day’s Range― - ―
52-Week Range₹502.20 - ₹891.80
Previous CloseN/A
Volume110.72K
Average Volume (3M)12.28K
Market Cap
₹18.48B
Enterprise Value₹21.21B
Total Cash (Recent Filing)₹1.60B
Total Debt (Recent Filing)₹2.86B
Price to Earnings (P/E)38.4
Beta1.00
Next Earnings
Jun 03, 2026EPS Estimate
5.2Next Dividend Ex-DateN/A
Dividend Yield0.38%
Share Statistics
EPS (TTM)4.90
Shares Outstanding32,438,670
10 Day Avg. Volume19,408
30 Day Avg. Volume12,281
Financial Highlights & Ratios
PEG Ratio0.98
Price to Book (P/B)2.95
Price to Sales (P/S)3.63
P/FCF Ratio-66.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)52.8
Revenue Forecast (FY)₹11.39B
Bulls Say, Bears Say
Bulls Say
Revenue Growth & High Gross MarginSustained double-digit revenue growth and a very high gross margin reflect strong demand for diagnostics and efficient cost structure. Combined with the company's mix of PPP and patient-facing services, this supports stable top-line growth and durable unit economics over the medium term.
Strong Balance Sheet And Low LeverageA high equity ratio and low debt-to-equity give the company financial flexibility to fund center rollouts and absorb cyclical dips without heavy refinancing. The conservative capital structure reduces solvency risk and supports competitive bidding on public contracts over time.
Solid Operating Cash ConversionOperating cash flows convert earnings into cash at a healthy rate, indicating quality of reported profits. Durable cash conversion helps fund working capital and service-level operations for labs and imaging, providing a foundation for steady operations if capex is managed.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow limits the company's ability to self-fund expansion and may force external financing or slower rollouts. For a capital-intensive diagnostics network, sustained negative FCF increases refinancing and execution risk until capex is better aligned with cash generation.
Moderate Operating And Net MarginsWhile gross margin is high, operating and net margins are only moderate, leaving limited cushion against tariff reductions or rising overheads. Improving operational efficiency is necessary to sustain returns, especially when competing on price in public contracts.
Dependence On PPP/Government ContractsHeavy reliance on public-private and government contracts exposes revenue to negotiated tariffs, renewal risk and policy changes. Contract-dependent volume and pricing create structural revenue variability and place emphasis on winning and retaining public tenders.
Krsnaa Diagnostics Limited News
KRSNAA FAQ
What was Krsnaa Diagnostics Limited’s price range in the past 12 months?
Krsnaa Diagnostics Limited lowest stock price was ₹502.20 and its highest was ₹891.80 in the past 12 months.
What is Krsnaa Diagnostics Limited’s market cap?
Krsnaa Diagnostics Limited’s market cap is ₹18.48B.
When is Krsnaa Diagnostics Limited’s upcoming earnings report date?
Krsnaa Diagnostics Limited’s upcoming earnings report date is Jun 03, 2026 which is in 55 days.
How were Krsnaa Diagnostics Limited’s earnings last quarter?
Krsnaa Diagnostics Limited released its earnings results on Feb 05, 2026. The company reported ₹4.9 earnings per share for the quarter, missing the consensus estimate of ₹6.067 by -₹1.167.
Is Krsnaa Diagnostics Limited overvalued?
According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued.
Does Krsnaa Diagnostics Limited pay dividends?
Krsnaa Diagnostics Limited pays a Annually dividend of ₹2.75 which represents an annual dividend yield of 0.38%. See more information on Krsnaa Diagnostics Limited dividends here
What is Krsnaa Diagnostics Limited’s EPS estimate?
Krsnaa Diagnostics Limited’s EPS estimate is 5.2.
How many shares outstanding does Krsnaa Diagnostics Limited have?
Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.
What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?
Krsnaa Diagnostics Limited reported an EPS of ₹4.9 in its last earnings report, missing expectations of ₹6.067. Following the earnings report the stock price went down -0.776%.
Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?
Currently, no hedge funds are holding shares in IN:KRSNAA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Dr. Lal PathLabs Limited
―
Medicamen Biotech Limited
―
Metropolis Healthcare Ltd.
―
Vijaya Diagnostic Centre Ltd.
―